摘要
目的 评价奥美拉唑( 洛赛克) 对肝源性溃疡(HU) 的疗效。方法 对251 例肝硬化经胃镜检查出溃疡的48 例患者,予每日晨服奥美拉唑20mg,疗程4 ~6 周,着重观察胃镜下溃疡愈合情况,并与同期消化性溃疡(PU) 疗效对比分析。结果 4 周愈合率HU 组中,十二指肠溃疡(DU) 为69 .2%(18/26 例),胃溃疡(GU) 为52.9% (9/17 例) ;PU 组中DU 与GU 均为100% (31/31 与6/6 例),两组比较差异有非常显著性(P< 0.01)。6 周愈合率HU 中DU 为84 .6% (22/26),GU 为82 .3(14/17 例) 。肝功能Child C级者溃疡愈合率明显降低。结论 奥美拉唑治疗HU 疗效满意。但疗程较PU 长。HU 的愈合于C级患者较低。
Objective To evaluate the effect oflosecin thetreatment of hepatogenous ulcer (HU) . Methods Forty eightpatients of HUreceived losec 20mg once a day for 4 - 6 weeks.The healing rates of HUwas observed by endoscopyin comparation with peptic ulcer (PU). Results In patients of HU,the overallhealing ratesfor DUat4 weeks was69 .2 % (18/26),theratesfor GUat4 weeks52.9 % (9/17) .In patientsof PU,theoverallhealing ratesfor DUand GUwas100% (31/31 ,6/6),with significantdiffcrence (P< 0.01) compraredto PUgroup.In patients of HU,theoverallhealingratesfor DUand GUat6 weeks was84.6% (22/26),82.3 %(14/17) ,respectively.Conclusion Ourdatashowedtheeffectoflosecintreat mentof HU wassatisfactory,butthe course oftreatment waslonger compare to patients of PU. However, the healing ratesin patients with Child Cgroup wasrelativelylow .
出处
《中华消化杂志》
CAS
CSCD
北大核心
1999年第S1期32-33,共2页
Chinese Journal of Digestion